Arrhythmogenic right ventricular cardiomyopathy

Changed by Yuranga Weerakkody, 30 Nov 2017

Updates to Article Attributes

Body was changed:

Arrhythmogenic right ventricular cardiomyopathy (ARVC), also referred to as arrhythmogenic right ventricular dysplasia (ARVD) or simply arrhythmogenic cardiomyopathy, is classified as a type of cardiomyopathy. It is seen particularly in young males and is one of the more common causes of sudden death in these patients. 

Epidemiology

The estimated population prevalence is thought to range around 1 in 1000-5000 8. It typically presents in young individuals. There is a recognised male predilection, with a male-to-female ratio of 2.7:1. Several reports suggest that there is a familial occurrence of ARVC of about 30-50%, with mainly autosomal dominant inheritance, various penetrance, and polymorphic phenotypic expression.

Clinical presentation

ARVC is characterised clinically by ventricular arrhythmias with left bundle branch block (LBBB) that may lead to cardiac arrest. As such, it may present as a sudden onset collapse or syncopal episode and should be a consideration in a young fit individual with such a presentation. 

Associations
  • as the name implies this is associated with fatal arrhythmias and sudden cardiac death
  • other nonfatal arrhythmias include
    • left bundle branch block: LBBB
    • ventricular tachycardia

Diagnosis is based on the presence of structural, histologic, electrocardiographic, arrhythmic, and genetic factors 4. This involves a combination of characteristic abnormalities in family history, electrocardiography, cardiac imaging as well as endomyocardial biopsy. 

Diagnostic criteria have also been developed, of which patients must have either two major criteria, one major and two minor criteria, or four minor criteria. See diagnostic criteria for arrhythmogenic right ventricular cardiomyopathy 2

Pathology

Two morphologic variants of ARVC have been reported: fatty and fibrofatty.

The fatty form is characterized by almost complete replacement of the myocardium without thinning of the ventricular wall, and it occurs exclusively in the right ventricle.

The fibro-fatty variant is associated with significant thinning of the right ventricular wall, and the left ventricular myocardial wall may also be involved 1-2.

Both idiopathic and familial aetiologies have been proposed (see epidemiology above) 2.  

As the name implies, it classically involves the right ventricle although, on autopsy studies, a sizeable number of cases also show a degree of left ventricular involvement.

Radiographic features

Plain radiograph

Chest radiographic findings are non-specific and can often be normal. May show evidence of right ventricular dilatation (best seen on a lateral view).

Echocardiography

The right ventricle is often dilated and hypokinetic.

MRI

Most sensitive imaging modality for diagnosis although image interpretation can still be difficult due to a degree of RV wall focal fatty infiltration (high signal on T1) in normal individuals 3. ARVC classically demonstrates fibro-fatty deposition in the right ventricular free wall, although this is not currently considered a part of the major or minor diagnostic criteria 9. ARVC also classically shows morphological features of right ventricular dilation and the ventricular wall may be thinned as a result. The left ventricle is usually spared (except in a very small proportion of cases 6). SSFP sequences may provide additional information on functional wall impairment. 

Other associated features include:

  • right ventricular aneurysm formation
  • diffuse right ventricular wall thinning resulting in severe global dilatation
  • segmental hypokinesia
CT

May show right ventricular dilation and fatty low attenuation to the right ventricular wall.

Cardiac MRI

MRI may show fatty infiltration in the right ventricle (and occasionally in the left ventricle) 8. MRI may also detect right ventricular dilatation and aneurysm formation as well as wall-motion abnormalities including right ventricular dyskinesia, a corrugated pattern to the right ventricular wall known as the “accordion sign”

Focal left ventricular dyskinesia may be present with fatty infiltration within the left ventricle. MRI is also helpful in evaluation of myocardial fibrosis and scarring.

Treatment and prognosis

ARVC is a progressive disease and will probably lead to right ventricular failure in the long term unless sudden cardiac death occurs beforehand.

The four therapeutic options in patients with ARVC include antiarrhythmic agents, catheter ablation, implantable cardioverter defibrillators, and surgery.

Differential diagnosis

Imaging differential considerations include:

  • -<p><strong>Arrhythmogenic right ventricular cardiomyopathy </strong><strong>(ARVC)</strong>, also referred to as <strong>arrhythmogenic right ventricular dysplasia </strong>or simply <strong>arrhythmogenic cardiomyopathy</strong>, is classified as a type of <a href="/articles/cardiomyopathy-whoisfc-1995-classification">cardiomyopathy</a>. It is seen particularly in young males and is one of the more common causes of sudden death in these patients. </p><h4>Epidemiology</h4><p>The estimated population prevalence is thought to range around 1 in 1000-5000 <sup>8</sup>. It typically presents in young individuals. There is a recognised male predilection, with a male-to-female ratio of 2.7:1. Several reports suggest that there is a familial occurrence of ARVC of about 30-50%, with mainly autosomal dominant inheritance, various penetrance, and polymorphic phenotypic expression.</p><h4>Clinical presentation</h4><p>ARVC is characterised clinically by ventricular arrhythmias with left bundle branch block (LBBB) that may lead to cardiac arrest. As such, it may present as a sudden onset collapse or syncopal episode and should be a consideration in a young fit individual with such a presentation. </p><h5>Associations</h5><ul>
  • +<p><strong>Arrhythmogenic right ventricular cardiomyopathy </strong><strong>(ARVC)</strong>, also referred to as <strong>arrhythmogenic right ventricular dysplasia (ARVD) </strong>or simply <strong>arrhythmogenic cardiomyopathy</strong>, is classified as a type of <a href="/articles/cardiomyopathy-whoisfc-1995-classification">cardiomyopathy</a>. It is seen particularly in young males and is one of the more common causes of sudden death in these patients. </p><h4>Epidemiology</h4><p>The estimated population prevalence is thought to range around 1 in 1000-5000 <sup>8</sup>. It typically presents in young individuals. There is a recognised male predilection, with a male-to-female ratio of 2.7:1. Several reports suggest that there is a familial occurrence of ARVC of about 30-50%, with mainly autosomal dominant inheritance, various penetrance, and polymorphic phenotypic expression.</p><h4>Clinical presentation</h4><p>ARVC is characterised clinically by ventricular arrhythmias with left bundle branch block (LBBB) that may lead to cardiac arrest. As such, it may present as a sudden onset collapse or syncopal episode and should be a consideration in a young fit individual with such a presentation. </p><h5>Associations</h5><ul>
  • -</ul><h5>CT</h5><p>May show right ventricular dilation and fatty low attenuation to the right ventricular wall.</p><h4>Treatment and prognosis</h4><p>ARVC is a progressive disease and will probably lead to right ventricular failure in the long term unless sudden cardiac death occurs beforehand.</p><p>The four therapeutic options in patients with ARVC include antiarrhythmic agents, catheter ablation, implantable cardioverter defibrillators, and surgery.</p><h4>Differential diagnosis</h4><p>Imaging differential considerations include:</p><ul>
  • +</ul><h5>CT</h5><p>May show right ventricular dilation and fatty low attenuation to the right ventricular wall.</p><h5>Cardiac MRI</h5><p>MRI may show fatty infiltration in the right ventricle (and occasionally in the left ventricle)<sup> 8</sup>. MRI may also detect right ventricular dilatation and aneurysm formation as well as wall-motion abnormalities including right ventricular dyskinesia, a corrugated pattern to the right ventricular wall known as the “accordion sign”</p><p>Focal left ventricular dyskinesia may be present with fatty infiltration within the left ventricle. MRI is also helpful in evaluation of myocardial fibrosis and scarring.</p><h4>Treatment and prognosis</h4><p>ARVC is a progressive disease and will probably lead to right ventricular failure in the long term unless sudden cardiac death occurs beforehand.</p><p>The four therapeutic options in patients with ARVC include antiarrhythmic agents, catheter ablation, implantable cardioverter defibrillators, and surgery.</p><h4>Differential diagnosis</h4><p>Imaging differential considerations include:</p><ul>

References changed:

  • 10. Rastegar N, Burt JR, Corona-Villalobos CP, Te Riele AS, James CA, Murray B, Calkins H, Tandri H, Bluemke DA, Zimmerman SL, Kamel IR. Cardiac MR findings and potential diagnostic pitfalls in patients evaluated for arrhythmogenic right ventricular cardiomyopathy. Radiographics : a review publication of the Radiological Society of North America, Inc. 34 (6): 1553-70. <a href="https://doi.org/10.1148/rg.346140194">doi:10.1148/rg.346140194</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/25310417">Pubmed</a> <span class="ref_v4"></span>
  • 11. te Riele AS, Tandri H, Bluemke DA. Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 16: 50. <a href="https://doi.org/10.1186/s12968-014-0050-8">doi:10.1186/s12968-014-0050-8</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/25191878">Pubmed</a> <span class="ref_v4"></span>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.